Ultrahuman M2 Live brings glucose monitoring to $130

Key Takeaways

• Ultrahuman M2 Live uses Abbott's Lingo and Libre 3 Plus sensors for continuous glucose monitoring without a prescription
• Platform costs $130 one-time with one sensor, or $100/month subscription with two sensors
• The Metabolic Score algorithm is clinically validated and published in Nature

Ultrahuman, the Bangalore-based health tech company known for its Ring AIR smart ring, has launched M2 Live, a continuous glucose monitoring platform priced at $130 for a one-time purchase. The system uses Abbott's Lingo Glucose Biosensor and is available over-the-counter, no prescription required.

This marks Ultrahuman's clearest push into metabolic health beyond its existing wearables business. The company previously expanded from its smart ring into red light therapy devices, and now targets the growing CGM consumer market with a platform that integrates glucose data with sleep, activity, and recovery metrics.

How does Ultrahuman M2 Live work?

M2 Live connects to Abbott's Lingo sensor and the Libre 3 Plus sensor. The sensors stream glucose data to your phone over Bluetooth LE, though initial activation requires NFC. Each sensor lasts about 14 days before needing replacement.

The companion app calculates a proprietary Metabolic Score, which Ultrahuman describes as a clinically validated marker of insulin sensitivity and glucose metabolism. The company has published supporting research in Nature, lending some scientific credibility to the scoring system.

Because M2 Live sits within Ultrahuman's broader platform, the system can pull data from the company's smart ring sensors. The company's Jade AI Biointelligence then correlates glucose patterns with sleep quality, heart rate variability, physical activity, recovery status, and skin temperature readings. This cross-referencing is where Ultrahuman sees its competitive edge over standalone CGM apps.

What does it cost?

Ultrahuman offers two pricing options. A one-time purchase at $130 includes a single sensor that lasts 14 days. The subscription model costs $100 per month and includes two sensors, essentially covering continuous monitoring.

Note that Abbott offers its own companion app for these sensors. You can use Abbott's app independently, but you lose access to the Metabolic Score algorithm and integration with Ultrahuman's other wearables data.

Who is M2 Live designed for?

Ultrahuman targets people with metabolic disorders: Type 2 diabetes, obesity, PCOS/PMOS, and hypertension. The platform also positions itself as a weight loss tool. It tracks what you eat throughout the day and monitors how different foods affect your glucose levels.

The system learns individual responses to specific foods and assigns each a score from 1 to 10. Over time, this builds a personal database of how your body handles different meals, theoretically guiding better portion control and food choices.

Ultrahuman also offers a community feature where users share what works for them, alongside an AI metabolic coach for personalized guidance.

The broader CGM market shift

Continuous glucose monitoring has traditionally been a medical device category, prescribed primarily for diabetics. The consumer wellness market is changing that. Companies like Levels, Nutrisense, and now Ultrahuman are betting that health-conscious consumers will pay for glucose insights even without a diabetes diagnosis.

The global CGM market is projected to reach over $50 billion by 2030, driven partly by this wellness crossover. With 537 million adults worldwide living with diabetes according to the International Diabetes Federation, the core medical market remains enormous. But the real growth question is how many non-diabetic consumers will adopt glucose monitoring as a lifestyle tool.

Ultrahuman has raised over $75 million in funding, including a Series B led by Alpha Wave Global. The company's Ring AIR sells for $299, positioning Ultrahuman in the premium wellness wearables tier. M2 Live extends that positioning into continuous glucose monitoring.

The Abbott partnership advantage

By building on Abbott's sensor technology, Ultrahuman sidesteps the regulatory and manufacturing challenges of developing its own CGM hardware. Abbott's Libre platform is the leading CGM sensor globally, giving Ultrahuman access to proven, FDA-cleared hardware.

This partnership model mirrors how smartphone apps layer software value on top of standardized hardware. Ultrahuman's bet is that the Metabolic Score algorithm and platform integration justify the premium over Abbott's own app experience.

Frequently Asked Questions

Does Ultrahuman M2 Live require a prescription?

No. M2 Live uses Abbott's Lingo sensor, which is available over-the-counter without a prescription.

How long do the glucose sensors last?

Each sensor lasts approximately 14 days before requiring replacement. The sensors are not reusable.

Can I use M2 Live without an Ultrahuman smart ring?

Yes. M2 Live works independently, though integration with the Ultrahuman Ring allows the platform to correlate glucose data with sleep, HRV, and activity metrics.

What is the Metabolic Score?

The Metabolic Score is Ultrahuman's proprietary algorithm measuring insulin sensitivity and glucose metabolism. The company states it is clinically validated with supporting research published in Nature.

How much does Ultrahuman M2 Live cost per year?

The subscription runs $100/month with two sensors included, totaling $1,200 annually for continuous monitoring.

Source: GSMArena.com / Peter